American Bio Medica Reaches Distribution Agreement With SiberHegner & Co. Ltd.Business Editors KINDERHOOK, N.Y.--(BUSINESS WIRE)--July 10, 2001 Swiss Marketing & Services Group to Add Sales Breadth for Rapid Drug Screen(tm) in Switzerland American Bio Medica medica (māˑ·dē·k Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ABMC ABMC American Battle Monuments Commission ABMC Alexian Brothers Medical Center (Illinois) ABMC Aviation Battle Management Concept ABMC Arrowbear Music Camp (California) ) today announced it had reached an agreement with SiberHegner, a leading international marketing and services group, that will pave the way for wider distribution of ABMC's Rapid Drug Screen in markets in Switzerland. The agreement includes an initial product order by SiberHegner for 2,610 units of ABMC's Rapid Drug Screen. Headquartered in Zurich, Switzerland, SiberHegner has a 135-year corporate history of marketing and distributing chemicals and pharmaceuticals, food ingredients, advanced technology products, high-quality consumer goods consumer goods Any tangible commodity purchased by households to satisfy their wants and needs. Consumer goods may be durable or nondurable. Durable goods (e.g., autos, furniture, and appliances) have a significant life span, often defined as three years or more, and and premium pet products. The privately owned company reports total annual sales of $625 million, and employs over 1,250 people worldwide in offices throughout Europe, Asia, and the Americas. Its United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. headquarters is in Baltimore. "This is a very powerful business alliance, and yet another important benchmark of the three-year business plan for American Bio Medica," said Robert L. Aromando Jr., chairman and chief executive officer of ABMC. "SiberHegner has an extensive network of relationships, and a broad technology portfolio that undoubtedly will help us leverage our brands." "Rapid Drug Screen is a reliable, practical technology that can compete in terms of both performance and price," commented Beat Heller, executive vice president of business unit pharmaceuticals, of SiberHegner. "We think it will be an important addition to the analytical toxicology resources we can offer customers." The total agreement covers three shipments of Rapid Drug Screen, with the second two installments in November 2001 and April 2002. SiberHegner has ordered various configurations of the on-site testing device, from nine-panel drug screens to ABMC's popular Rapid One(tm) test for individual illicit drugs. About American Bio Medica American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate on-site drugs-of-abuse diagnostic kits, sprays and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services worldwide. The company's global distributors target the workplace, physicians, corrections, clinical and educational markets. ABMC's Drug Detector(tm) identifies minute traces of illegal drugs on surfaces, while the company's Rapid Drug Screen tests Andy Warhol's Screen Tests consist of several-minute unbroken shots of Factory regulars, Warhol superstars, guests, friends, or anyone he thought has "star potential". Warhol would place them in a booth, and tell them to stare at the camera and not blink. individuals and is proven to correlate greater than 99% with the standard laboratory screening test. Forward-looking statements in this release are made pursuant to the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, intellectual property rights and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion